Physician

Abhishrut Pramod Jog, MD

According to 2025 Medicare claims, Abhishrut Jog, MD (NPI: 1528620036) practices critical care (intensivists) in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bronx, NY. This provider's primary affiliated billing organization is MONTEFIORE MEDICAL CENTER (NPI: 1063525152; TIN: 131740114) and primary practice location at 10467-2401.

Jog's data goes back to 2015 and runs through 2024. Part D data shows 1,292 prescription claims across 156 beneficiaries totaling $367,954 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). Open Payments data shows 2 records totaling $50. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $20,993 to $367,954. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	49	316	$20,993
2020	70	447	$43,493
2021	61	670	$90,676
2022	147	874	$199,835
2023	169	1,383	$521,050
2024	156	1,292	$367,954

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	271	8,670	$178,650
Incruse Ellipta	Umeclidinium Bromide	124	3,960	$44,627
Breo Ellipta	Fluticasone/Vilanterol	70	2,220	$28,723
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	43	1,290	$18,646
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	23	690	$13,576

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$50	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abhishrut Pramod Jog, MD?

Tedicare shows public-source Medicare data for Abhishrut Pramod Jog, MD (NPI 1528620036), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abhishrut Pramod Jog, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abhishrut Pramod Jog, MD?

Abhishrut Pramod Jog, MD is linked to MONTEFIORE MEDICAL CENTER (billing NPI 1063525152) in the available physician profile data.

Does Abhishrut Pramod Jog, MD have Open Payments data?

Abhishrut Pramod Jog, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.